Network structure of brain atrophy in de novo Parkinson's disease

Network structure of brain atrophy in de novo Parkinson's disease

We mapped the distribution of atrophy in Parkinson's disease (PD) using magnetic resonance imaging (MRI) and clinical data from 232 PD patients and 117 controls from the Parkinson's Progression Markers Initiative. Deformation-based morphometry and independent component analysis identified...

Full description

Bibliographic Details
Main Authors:	Yashar Zeighami, Miguel Ulla, Yasser Iturria-Medina, Mahsa Dadar, Yu Zhang, Kevin Michel-Herve Larcher, Vladimir Fonov, Alan C Evans, D Louis Collins, Alain Dagher
Format:	Article
Language:	English
Published:	eLife Sciences Publications Ltd 2015-09-01
Series:	eLife
Subjects:	MRI substantia nigra basal ganglia independent component analysis deformation-based morphometry
Online Access:	https://elifesciences.org/articles/08440

Similar Items

Synaptic Plasticity in Basal Ganglia Output Neurons in Parkinson's Disease Patients
by: Prescott, Ian
Published: (2009)

Synaptic Plasticity in Basal Ganglia Output Neurons in Parkinson's Disease Patients
by: Prescott, Ian
Published: (2009)

Glutamatergic pallidothalamic projections and their implications in the pathophysiology of Parkinson’s disease
by: Pedro Barroso-Chinea, et al.
Published: (2008-09-01)

Beyond reward prediction errors: the role of dopamine in movement kinematics
by: Joseph eBarter, et al.
Published: (2015-05-01)

In Vivo Dopamine Efflux is Decreased in Striatum of both Fragment (R6/2) and Full-length (YAC128) Transgenic Mouse Models of Huntington’s Disease
by: Joshua W Callahan, et al.
Published: (2011-07-01)

Continuous bilateral infusion of vigabatrin into the subthalamic nucleus: Effects on seizure threshold and GABA metabolism in two rat models
by: Laura Gey, et al.
Published: (2016-07-01)

To dopamine and beyond, a review of the mechanisms of Parkinson's disease
by: Chester, Andrew
Published: (2018)

A Direct Cortico-Nigral Pathway as Revealed by Constrained Spherical Deconvolution Tractography in Humans
by: Alberto Cacciola, et al.
Published: (2016-07-01)

Vigabatrin for focal drug delivery in epilepsy: Bilateral microinfusion into the subthalamic nucleus is more effective than intranigral or systemic administration in a rat seizure model
by: Sonja Bröer, et al.
Published: (2012-05-01)

Deep brain stimulation changes basal ganglia output nuclei firing pattern in the dystonic hamster
by: Arthur Leblois, et al.
Published: (2010-05-01)

A Review of the Pedunculopontine Nucleus in Parkinson's Disease
by: Isobel T. French, et al.
Published: (2018-04-01)

Utility of quantitative susceptibility mapping and diffusion kurtosis imaging in the diagnosis of early Parkinson’s disease
by: Samantha Tan, et al.
Published: (2021-01-01)

Extrastriatal dopaminergic circuits of the basal ganglia
by: Karen Suzanne Rommelfanger, et al.
Published: (2010-10-01)

Corrigendum: Morphological evidence for dopamine interactions with pallidal neurons in primates
by: Lara eEid, et al.
Published: (2015-09-01)

Midbrain dopaminergic neurons generate calcium and sodium currents and release dopamine in the striatum of pups
by: Diana Carolina Ferrari, et al.
Published: (2012-03-01)

Morphological evidence for dopamine interactions with pallidal neurons in primates
by: Lara eEid, et al.
Published: (2015-08-01)

The use of phosphorescence oxygen analyzer to measure the effects of rotenone and 1-methyl-4-phenylpyridinium on striatal cellular respiration in C57BL6 mice
by: Mariam Al Shamsi, et al.
Published: (2021-06-01)

Not Part of the Temporal Lobe, but Still of Importance? Substantia Nigra and Subthalamic Nucleus in Epilepsy
by: Sonja Bröer
Published: (2020-12-01)

Lack of depotentiation at basal ganglia output neurons in PD patients with levodopa-induced dyskinesia
by: I.A. Prescott, et al.
Published: (2014-11-01)

Unmasking adenosine 2A receptors (A2ARs) in monkey basal ganglia output neurons using cholera toxin subunit B (CTB)
by: Natasha Luquin, et al.
Published: (2012-09-01)

l-DOPA-induced dyskinesia in hemiparkinsonian rats is associated with up-regulation of adenylyl cyclase type V/VI and increased GABA release in the substantia nigra reticulata
by: Claudia Rangel-Barajas, et al.
Published: (2011-01-01)

Regulation of substantia nigra pars reticulata GABAergic neuron activity by hydrogen peroxide via flufenamic acid-sensitive channels and KATP channels
by: Christian R Lee, et al.
Published: (2011-04-01)

Dopaminergic denervation impairs cortical motor and associative/limbic information processing through the basal ganglia and its modulation by the CB1 receptor
by: Mario Antonazzo, et al.
Published: (2021-01-01)

Kindling as a model of temporal lobe epilepsy induces bilateral changes in spontaneous striatal activity
by: Saskia Kücker, et al.
Published: (2010-03-01)

Glutamate-induced reversal of dopamine transport is mediated by the PKC signalling pathway
by: Opazo Dávila, Luis Felipe
Published: (2009)

Cervical dystonia: a disorder of the midbrain network for covert attentional orienting.
by: Michael eHutchinson, et al.
Published: (2014-04-01)

Regional neural activity within the substantia nigra during peri-ictal flurothyl generalized seizure stages
by: Jana Velíšková, et al.
Published: (2005-12-01)

Pedunculopontine neurons are involved in network changes in the kindling model of temporal lobe epilepsy
by: Marc W. Nolte, et al.
Published: (2006-07-01)

Benefits and risks of intranigral transplantation of GABA-producing cells subsequent to the establishment of kindling-induced seizures
by: Marc W. Nolte, et al.
Published: (2008-09-01)

Severity of Dyskinesia and D3R Signaling Changes Induced by L-DOPA Treatment of Hemiparkinsonian Rats Are Features Inherent to the Treated Subjects
by: Sacnité Albarrán-Bravo, et al.
Published: (2019-09-01)

Mitochondrial DNA mutations in Parkinson's disease brain
by: David K. Simon, et al.
Published: (2017-04-01)

Transcranial sonography in Parkinson’s disease
by: I. V. Bayborodina, et al.
Published: (2018-03-01)

The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease
by: E. Ilijic, et al.
Published: (2011-08-01)

An early axonopathy in a hLRRK2(R1441G) transgenic model of Parkinson disease
by: Patricia Tagliaferro, et al.
Published: (2015-10-01)

Effect of potassium channel blocker Tetraethylammonium pretreatment on prevention of the 6-OHDA-induced chronic Parkinson's disease in rats
by: H. Haghdoost-Yazdi, et al.
Published: (2016-06-01)

Changes of neurons and blood vessels of human substantia nigra in aging: Morphometric study
by: Krivokuća Zdenka, et al.
Published: (2017-01-01)

Environmental Risk Factors and Parkinson's Disease: Selective Degeneration of Nigral Dopaminergic Neurons Caused by the Herbicide Paraquat
by: Alison L. McCormack, et al.
Published: (2002-07-01)

Transcranial parenhymal sonography in the diagnosis of Parkinson's disease
by: Mijajlović Milija, et al.
Published: (2008-01-01)

The application value of quantitative susceptibility mapping in evaluating substantia nigra "swallow tail sign" in the diagnosis of Parkinson's disease
by: Xiao-jun GUAN, et al.
Published: (2018-04-01)

Dietary and Intraperitoneal Administration of Selenium Provide Comparable Protection in the 6-Hydroxydopamine Lesion Rat Model of Parkinson's Disease
by: Cecilia M. Fox, et al.
Published: (2007-01-01)

Cannot write session to /tmp/vufind_sessions/sess_pavhe6bleovleue6sfnq39fmqi